Contact Jacoby & Meyers
Dangerous Drug Lawyers
Call us Today 800-977-5614

Gleevec is used to treat certain types of leukemia such as Philadelphia chromosome positive chronic myeloid leukemia (CML). It has also been prescribed to treat certain tumors in the digestive system. Gleevec is manufactured by Novartis and in 2006 generated $1.2 billion within six months. It was approved by the FDA in 2001 to treat CML. Gleevec is in a class of agents that inhibits specific tyrosine kinase enzymes.
A new warning was placed on Gleevec labels after it was thought to cause heart failure in 10 patients. Heart failure is a dangerous disease which can often times be fatal. The medication is thought to be toxic to cardiac cells.
In one case, a woman developed a case of Rhabdomyolysis—a disease that can be extremely damaging to kidneys. This case was researched and published in the New England Journal of Medicine.
Serious side effects may include:
Less serious Gleevec side effects may include:
Lawyer Advertising. This website is designed for general information only, and in no way is intended to constitute legal advice nor the formation of a lawyer/client relationship without a signed, written agreement. Testimonials or endorsements do not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter. You pay no fees or costs unless we recover for you. This website contains dramatizations. Prior results are not a guarantee of a future outcome. Jacoby & Meyers does not accept all cases and works cooperatively with co-counsel and/or other law firms with whom it has joint agreements who might potentially handle your cases. We look forward to helping you with your claim.
© 2012-2025 Jacoby & Meyers. All rights reserved.